CD4 and tuberculosis: In a clinical trial that tested boosting of mycobacteria-specific responses with the TB vaccine candidate, MVA85A, low but detectable Ag85A-specific CD45RA+ CCR7+ CD27+ naive-like CD4+ T cell responses were observed before MVA85A vaccination and frequencies of these cells remained unchanged after vaccination (23).